noscript

News and Announcements

Universal Biosenors Acquires Hemostasis Reference Laboratory

  • Published December 19, 2016 12:57PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

19th December 2016 – ASX Announcement

Universal Biosensors Inc (ASX: UBI) has announced that its wholly-owned Canadian operating subsidiary has signed an agreement with LifeLabs LP (LifeLabs) to acquire the assets of LifeLabs’ Hemostasis Reference Laboratory business (HRL) in preparation for future increased production requirements of Siemens’ Xprecia Stride™ test strips.

The HRL business has provided high-quality coagulation testing and calibration services to international customers for more than 20 years, including 5 years of services for UBI. HRL has one of the most diverse offerings of specialised coagulation services in the world.

To view the full announcement please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now